Sustained extracellular signal-regulated kinase (ERK)-1/2 activation is proposed as one of the major mechanisms in NED of prostate cancer cells, playing a critical role in converging of multiple signaling pathways for NED [10]. The gene discussed is MAPK3; the disease is Familial prostate cancer.